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Abstract
Keratoconus is one of the most important corneal diseases that causes prevent-
able blindness, so we decided to review the main techniques for improving visual 
acuity in patients with progressive and nonprogressive keratoconus, in order to 
expand knowledge in relation to the range of therapeutic possibilities that exist 
today and the benefits and risks of each of these alternatives.
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1. Introduction
Keratoconus is an asymmetric bilateral corneal disease, defined as noninflam-
matory in which the cornea changes its usual morphology and begins to cause a 
corneal thinning with protrusion of the thinnest area. It usually begins between 
the first and second decade of life, without predilection for sex, and progresses 
gradually until the third decade with deterioration of visual acuity in the form of 
irregular myopic astigmatism that does not improve with the usual existing correc-
tion measures (frame lenses or soft contact lenses) [1, 2].
Histopathological changes include disruption of Bowman’s layer, stromal and 
epithelial thinning, folding or rupture of Descemet’s membrane in severe cases, and 
a variable amount of scarring, especially in the anterior stroma, always with normal 
endothelium [2].
Some of the risk factors described are eye rubbing, asthma, a history of aller-
gic rhinitis, or allergic conjunctivitis, as well as a family history of keratoconus, 
although there is no inheritance or genetic pattern involved so far [3, 4].
In relation to the clinic, it is presented as a decrease in progressive visual acuity 
without improvement with correctors.
About the treatment, there are different approaches according to the objective 
planned. For correction of visual acuity in mild cases, it can be achieved for rigid 
gas-permeable lenses; in moderate to severe degrees, contact lenses are also used, 
but surgical techniques are added such as intrastromal rings, toric intraocular 
lenses, refractive phakic toric lens surgery, and lamellar and penetrating corneal 
transplants.
About progressive keratoconus there are two lines of treatment, as a first line to 
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acuity and quality of life of the patient. Currently the only FDA-approved treatment 
to stop the progression of the disease since April 18, 2016 is corneal collagen cross-
linking (CXL) [4].
2. Visual acuity improvement techniques in patients with keratoconus
Intrastromal corneal rings
Toric intraocular lenses of anterior and posterior chamber
Corneoscleral contact lens
Lamellar and penetrating corneal transplant
2.1 Corneoscleral contact lens (CScL)
Keratoconus patients tend to be complicated to treat because they are forced to 
leave their glasses frequently due to oscillations in their refraction because their 
measurements are unstable and must continually adapt to new glasses or other 
types of devices to achieve an optimal visual acuity [5]. The visual correction of 
the keratoconus will depend on the stage in which it is found; in the early stages 
astigmatism can be corrected with glasses; however, when it is moderate to severe, 
contact lenses become the most appropriate option before placement of intrastro-
mal rings or corneal transplantation [6].
Contact lenses for the treatment of keratoconus were induced by Adolf Fick in 
1888 [6]. The corneoscleral contact lens (CScL) are rigid oxygen-permeable gas 
lenses and are composed of fluorosilicone acrylate; these rest partially on the cornea 
and conjunctival tissue and are used to improve vision in patients with high or 
irregular astigmatism either secondary to keratoconus, marginal pellucid degenera-
tion, keratoglobus, or posttransplant astigmatism, as well as other pathologies such 
as Steven-Johnson syndrome, scar pemphigoid, or graft versus host disease may 
require its use, and also for patients who do not tolerate conventional gas-permeable 
rigid lenses [7, 8].
There are several types of contact lenses that can be used for the correction of 
visual acuity, astigmatism, and high-order aberrations in patients with keratoconus 
such as the corneoscleral contact lenses mentioned above, the mini-scleral contact 
lens (MSCL), the piggyback contact lens, and the rigid gas-permeable contact lens 
(RGPCL), being the hybrid contact lens (HCLs), soft toric lenses (STCLs), and 
corneoscleral contact lens (CScL) the most used for the correction of refractive 
error reporting excellent comfort and better vision with the corneoscleral contact 
lenses since the latter tends to be more accessible to use than conventional [5, 6, 9].
There are two types of scleral lenses: those ventilated by air or fenestrated or 
those ventilated by fluid or not fenestrated; according to Rathi et al. [7], fenestrated 
lenses tend to compromise visual acuity because air bubbles can enter the visual axis 
altering vision, while this does not happen with non-fenestrated ones. There is a 
difference between mini-scleral lenses that have less corneal clearance but are likely 
to get stuck in the cornea due to the suction vacuum and its smaller diameter [7].
Corneoscleral contact lenses have factors that can affect your refractive per-
formance such as the scleral or haptic portion that rests on the sclera and should 
be between 12.60 and 13.5 mm, the vault that is involved in the corneal and limbal 
clearance, the base curvature which should vary between 5.8 and 9.2 mm, the 
peripheral or scleral curves ranging from 5 to 6 to 11.4 mm, and the central optical 
portion that should be 0.20–0.27 mm more than the horizontal diameter of the iris, 
and its powers range from +20.00 to −25.00 D so that when making the calculation 
of the lens and its adjustment, these three factors must be taken into account [7, 8].
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The advantages of these lenses are that they are less mobile, focus better on the 
cornea, and have no contact with it so it does not cause irritation discomfort since they 
settle on the conjunctiva and the sclera; the ideal measures are between 15 and 17 mm 
of diameter or more. One of the advantages of this type of contact lenses is that they 
create a new ocular surface to compensate for the optical system so they must be filled 
with liquid before being placed and can be used for a longer time than conventional 
ones as long as the height of the vault is larger, so it is usually comfortable for some 
patients given the extended hours of use without complications [5–7, 10].
The disadvantage of soft, silicone hydrogel and permeable gas lenses concerning 
scleral lenses is that they cannot neutralize irregular astigmatism, so they do not 
provide visual acuity as suitable as corneoscleral contact lenses [5, 6].
Soft toric lenses (STCLs) are limited for the correction of astigmatism in an 
irregular cornea but are comfortable and are only indicated in patients with early 
keratoconus [6]. The corneoscleral contact lenses correct astigmatism through 
the fluid reservoir, and the haptic should be aligned with the sclera to position it 
properly and avoid high-order aberrations and correct them [8, 10].
On the other hand, RGPCL improves corneal irregularities through the tear 
layer between the lens and the anterior corneal surface and decreases higher-
order aberrations because they provide a regular refractive surface but tend to be 
intolerable and are indicated in mild to moderate keratoconus. HCLs have a rigid 
central part and a soft peripheral part to reduce discomfort and improve visual 
acuity but still develop many complications. MSCL and CScL improve visual 
acuity, are comfortable, and delay the need for keratoplasty in the eyes with 
advanced keratoconus; these lenses rest in the sclera without touching the cornea 
or limbus but should be used with appropriate ophthalmic solutions to reduce 
turbidity [6, 8, 10].
In the study of Saraç et al. [6], it was determined that the uncorrected visual 
acuity (UCVA) of users with MSCL, CScL, and RGPCL was greater than the users 
of STCL; topographic astigmatism in MSCL and CScL was greater than those of the 
STCL, but the cones that were in the center had a spectacle-corrected visual acu-
ity (SCVA) lower. In conclusion, MSCL and CScL are good alternatives to RGPCL 
and HCL for the correction of visual acuity since it achieves more efficient levels 
of visual acuity than other types. The study it was also determined that patients 
undergoing corneal collagen crosslinking (CXL) had a better visual acuity than 
those who had not undergone this treatment, so that a condition to achieve adequate 
visual acuity can also be submitted to patients to this type of treatment and then 
adjust the contact lenses.
According to Montalt et al. [10], residual high-order aberrations remained high 
compared to normal eyes after the use of CScL; this study highlights that although 
spherical and high-order aberrations were improved after the use of CScL for 
1 year, it is not clinically significant since they are only corrected at the time of use 
without anatomically modifying the cornea after use.
The CScL has decreased the incidence of performing corneal transplants either 
PK or DALK; these contact lenses are used in mild to moderate keratoconus and 
constitute a conservative route for treatment, and their advantage is that they are 
reversible; however, its high cost and perhaps its difficulty in placement may limit 
its use in some patients. Patients should be informed about the total reversibility 
of CScL unless adequate visual acuity is not achieved, and the patient must be 
informed of the complications of transplantation, such as glaucoma, high post-
keratoplasty astigmatism, ametropia, or anisometropia, that tend to be difficult to 
correct to provide a more appropriate visual correction [11].
There are patients who, although they have implanted intracorneal lens seg-
ment (ICRS), will require a certain degree of visual correction, and in some cases 
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corneoscleral contact lens, conventional or customized soft lenses, and rigid gas 
permeable, hybrid or piggyback contact lens can be complemented [8].
It should be noted that after the insertion of the ICRS, the anterior and posterior 
cornea may undergo certain variations in its surface so that the visual quality, the 
increase in corneal aberrations, and the alteration of the contrast sensitivity can be 
affected by the irregularity that this ICRS tends to produce; one option is to place 
corneoscleral contact lens since acceptable visual acuities and decreased high-order 
aberrations or vertical coma have been achieved; therefore, despite the fact that 
the placement of ICRS can contribute to the treatment of keratoconus, they induce 
aberrations that the ICRS cannot control and can be complemented with CScL [8].
The use of CScL showed no adverse effects such as corneal edema, compromised 
areas of the cornea, or corneal physiological deterioration. The visual quality was 
maintained; the number of hours of use of the lens and the comfort was adequate so 
it is a good option for additional correction in patients who require it [8].
2.2 Intrastromal corneal rings
The intrastromal rings correspond to small circular segments of biocompatible 
material (polymethylmethacrylate (PMMA)), which are inserted into the corneal 
thickness, specifically in the stromal layer in order to regularize the surface and 
improve the main refractive defect. Several studies show successful results in relation 
to corneal remodeling, but the evidence is scarce to show effect on its progression [1].
It is thought that the insertion of corneal implants results in a flattening of the 
corneal center with the consequent reduction of myopia and astigmatism that 
patients with keratoconus usually suffer, also generating a biomechanical support 
of the thin ectatic cornea. A tunnel is performed in the corneal stroma manually or 
assisted by femtosecond, and the intrastromal implant is inserted. This implant can 
be removed at any time, but usually they are removed only in case of complications 
or displacements of their original position [2].
Changes in the corneal structure can be explained by Barraquer’s law, in which 
when a material is added to the corneal periphery or the same amount of material 
is removed from the area of  the central cornea, a flattening effect is achieved. On 
the other hand, when a material is added to the center or removed from the corneal 
periphery, the curvature of the surface protrudes. It is postulated that the corrective 
results vary according to the thickness and diameter of the segment [12].
Each segment has a double effect: one of flattening, through the virtual line that 
connects the two terms of the segments, and another of protrusion perpendicular 
to the line reached by the action of the ring established by the difference between 
the plane of the segment and the plane of the cornea in the insertion area. With this, 
each segment flattens the axis parallel to the line and protrudes the perpendicular 
axis, which is why the segments are implanted in the most protruding axis [12]. In 
addition, it has been seen that the most flattening action is greater when the arc is 
longer and, on the contrary, the protrusion action is greater when the arc is smaller. 
The general flattening is greater with thicker segments [13].
Most publications suggest that the indications for intrastromal segments are 
patients with moderate keratoconus with a clear optic zone and those who are 
intolerant of contact lenses. The upper limit of K max should not be greater than 60 
D, the patient should not have any scar on the visual axis, and the cornea should be 
at least 350 mm thick by ultrasonic pachymetry in the optical zone or over the area 
in which the segments will be installed and the refractive error less than −6 D [14].
The corneal segments can be implanted using manual techniques or assisted by 
femtosecond laser. It is believed that the creation of the mechanical tunnel is more 
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complex and dependent on the skill of the surgeon; however, the technique with the 
femtosecond laser is faster and more precise, and with this a better reproducibility 
is achieved [15].
There are few studies that describe visual and refractive results in relation to 
implant depth to date, which have delivered results without significant differences [16].
On the other hand, several studies have evaluated with very good results the 
combination of cross-linking treatments and implants of intrastromal rings, 
because it is postulated that the first is the only effective treatment to stop the 
progression of the disease and the second for visual and refractive improvement 
without having a great implication in its progression [17–21]. ICRs combined with 
CXL showed that UDVA improved 0.12 logMAR at 12 months of follow-up, CDVA 
worsened 0.03 logMAR at 12 months of follow-up, but the mean sphere and cylin-
der component improved 3.03 ± 1.99 and 1.99 ± 0.96 D, respectively, at 12 months 
of follow-up. Keratometry improved 4.31 ± 2.62 D at 12 months of follow-up. Thus, 
UDVA, refraction, and keratometry improved to a greater degree than if only the 
ICR procedure was used [22].
Regarding the complications of the implant of rings, the systematic review by 
Izquierdo et al. [22] carried out in 1325 eyes showed that complications are rare but 
do occur. Intraoperative complications are mainly linked to the construction of the 
tunnel in manual techniques. Decentration of the segments, inadequate depth of 
the tunnel, and asymmetry of the segments are the most frequent. Postoperative 
complications include ring segment extrusion, corneal neovascularization, corneal 
haze, segment migration, corneal melting, and infectious keratitis, among others. 
Related to the combined procedure, the primary complications in the ICR group 
were white deposits (57 [5.75%]), epithelial defects (56 [5.65%]), extrusion (21 
[2.11%]), decentration (14 [1.41%]), segment migration (6 [0.6%]), and halos and 
glare (6 [0.6%]). In the ICR and CXL group, the main complications were edema 
(17 [5.08%]), extrusion (2 [0.59%]), perforation (2 [0.59%]), and corneal melting 
(1 [0.29%]) [22].
2.3 Phakic anterior IOLS for keratoconus
Several surgical options have been reported for patients undergoing corneal 
transplants secondary to keratoconus with refractive errors that are difficult to 
correct or patients with keratoconus and virgin corneas that do not tolerate contact 
lenses or who want the independence of the glasses. The variety of treatment is 
wide, such as photorefractive keratectomy, corneal wavefront-guided customized 
ablation, corneal relaxing incisions, small incision lenticule extraction, or intrastro-
mal corneal rings. However, the previous chamber iris-fixated phakic intraocular 
lens (ACIF-PIOL) has taken advantage of other correction techniques that can be 
provided to the patient for their safety and effectiveness [23].
The toric Artisan (Ophtec BV) is a one-piece polymethylmethacrylate intra-
ocular lens with a 5 mm optical zone, and a concave-convex shape is fixed to the 
iris and corrects a sphere from −23.00 D to +14.00 D and a cylinder of −1.00 D to 
−7.50 D. While the Artiflex toric intraocular lens (Ophtec BV) has a 6 mm optical 
zone and a concave-convex shape, it has a flexible polysiloxane optics and two rigid 
polymethyl methacrylate haptics and corrects spheres from −1.00 D to −13.50 D 
and cylinders −1.00 D to −5.00 D [24, 25].
This technique has the advantage to preserve the integrity of the post-transplant 
graft, prevent tissue ablation, having no risk of postoperative turbidity, and cor-
recting high degrees of spherical and astigmatic refraction, and they are stable, 
safe, and effective and can correct elevated refractive errors [24–27].
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It should be noted that the treatment with anterior chamber phakic intraocular 
lens must be complemented with the corneal collagen cross-linking before implan-
tation to maintain the keratometry and a stable refraction; these phakic lenses are 
indicated in patients with mild to moderate progressive keratoconus with regular 
myopic astigmatism. The implementation of pIOL 6 months after the corneal 
collagen cross-linking is recommended to consider changes in refractive errors and 
keratometry values that could alter the lens calculation [23–25, 28].
Before placing the ACIF-PIOL, all sutures should be removed in the case of 
posttransplant patients, and the candidate patients must have a stable keratoconus; 
these are not recommended in patients with newly diagnosed keratoconus or young 
patients with progressive keratoconus [24, 25, 27]. The implementation of anterior 
chamber phakic intraocular lens can improve a UDVA from 20/40 to 20/20 accord-
ing to the Snellen scale with a nonsignificant loss of endothelial cells; in the same 
way, an annual request is recommended for studies such as specular microscopy and 
anterior segment optical coherence tomography to monitor corneal changes [24, 28].
Some complications that may result from the implantation of this type of lens 
are endothelial cell damage, cataract formation, glare, haptic disintegration, pig-
mentary dispersion that can cause pigmentary glaucoma, and the corneal incision 
that can modify residual astigmatism, but they are very rare [26, 27].
In general, visual rehabilitation in patients, after the insertion of the anterior 
chamber phakic intraocular lens, is quite rapid, with maximization of vision and an 
optimal focus within the eye, without serious complications, and can be considered 
as an alternative treatment before transplantation because it is less invasive [25–27].
2.4 Implantable collamer toric lenses
The implantable collamer lens (ICL; Visian; STAAR Surgical, Nidau, 
Switzerland), which is used as a posterior chamber pIOL, is made from collamer, a 
biocompatible hydrophilic copolymer of collagen and hydroxyethyl methacrylate 
with an ultraviolet light. The lens is implanted in phakic patients in the posterior 
chamber, between the iris and the anterior lens capsule, without making contact 
with it so as not to cause cataracts or any other complication. There are toric 
devices, and with spherical correction, the toric models (Visian TICL) were devel-
oped in 1998, but only in 2006 it gets approved by the FDA and marketed for use.
A toric ICL is typically indicated for the correction of myopia in adults aged 
21–40y with myopia up to −18.0 diopters (D) with up to 6.0 D of astigmatism. Toric 
ICL cannot correct irregular corneal astigmatism; therefore, it is an alternative 
method to correct myopia and myopic astigmatism in the eyes with stable KC for 
partial visual rehabilitation.
Toric models are identical in material, chromophore, haptic design, size, and 
thickness to spherical models. It has a central convex-concave optical zone with a 
cylindrical component intended to correct astigmatism. Usually with the identi-
fication by extended alignment marks that orient the surgeon with respect to the 
degrees and direction of rotation that he has to do in relation to the horizontal axis 
to achieve a correct alignment.
Regarding the calculation of the power of the ICL, it is performed with nomo-
grams provided by the manufacturer according to the patient’s refraction, axial 
length, curvature and corneal thickness, distance to the vertex, depth of the 
anterior chamber, and the dimensions of white to white and of sulcus to sulcus, so 
as to determine the most appropriate ICL size for each patient.
A toric ICL corrects only spherical and cylindrical errors of refraction; it cannot 
correct HOAs caused by an irregular corneal shape. Patients who have a good 
spectacle-corrected visual acuity would benefit from toric ICL implantation. A toric 
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ICL does not induce HOAs. The aberrations associated with an irregular cornea in 
KC that are uncorrected by the pIOL have an effect on the final visual quality. A 
phakic toric ICL can correct a high degree of myopic astigmatism without inducing 
new HOA. High corneal irregularity limits the potential visual acuity and may need 
another surgery to make the cornea more regular [29, 30].
2.5 Penetrating keratoplasty
As we know, the cornea is a transparent dome-shaped surface that, from a micro-
scopic point of view, is composed of six layers that from the outside inward correspond 
to the stratified epithelium that helps keep the ocular surface smooth and provides a 
barrier against the external injury; the Bowman layer, an acellular structure that does 
not regenerate after damage; the stroma, which has anatomical and biochemical prop-
erties that maintain the physical stability of the corneal shape and transparency; the 
Dua layer, which would measure only 15 μm thick and would be located between the 
stroma and Descemet’s membrane; the Descemet’s membrane, which is 10 μm thick 
and can be easily separated from the stroma regenerating rapidly after trauma; and 
finally the endothelium, a thin layer of cells that maintain the hydration of the corneal 
stroma in a gradual manner and contribute to maintaining corneal transparency [31].
Due to the layered or lamellar characteristic of the cornea and the partial or 
complete commitment of the disease or condition that leads to the decision to 
perform a corneal transplant, two types of management can be distinguished: those 
that involve all the corneal thickness and which are lamellar, depending on the layer 
of the cornea affected.
Penetrating corneal transplantation is a surgical procedure in which the entire 
corneal is replaced by healthy donated tissue [32]. In DALK, the epithelium, the 
Bowman membrane, and a small part of the stroma are replaced, leaving the 
Descemet’s membrane and the endothelium undamaged.
Penetrating keratoplasty (QPP) has been the technique traditionally used during 
the twentieth century, independent of the cause of the transplant requirement. The 
first technically successful cornea transplant with human graft was performed by 
Power et al. [33]; however, a loss of corneal transparency was recorded at approxi-
mately 20 days [34].
Penetrating technique has been associated with multiple surgical complications 
such as the risk of tissue rejection, infections, and high astigmatism related to the 
need to ensure a tight seal for the donor graft [35–37].
The aforementioned complications, mainly graft rejection, have led to the 
development of new surgical techniques in which only the damaged cornea layer is 
replaced [32]. Lamellar techniques have been gaining popularity in recent decades 
and have involved preserving the healthy tissue of the recipient cornea by replacing 
only the compromised portion [38].
If we consider that the visual loss that affects the person with visual disability 
and that requires a corneal transplant has repercussions in the psychological, social, 
and labor, severely affecting their quality of life, there is no doubt that vision is 
one of the most important aspects of the functional activity of people. Our society 
attaches great importance to visual communication, to the point that those people 
who cannot make full use of this sense begin to be marginalized from the world 
around them, directly or indirectly.
2.6 Deep anterior lamellar keratoplasty (DALK)
The objective of the corneal transplant is to achieve an acceptable visual acuity 
with a minimum of retraction error and with a long duration. DALK was introduced 
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by Eduardo Archila in 1984 [39]; it is a very innovative technique indicated for 
patients who have no compromise of the corneal endothelium or Descemet’s mem-
brane and for mild cases of keratoconus [40–45].
This type of transplant consists of removing the diseased stroma from the 
cornea and separating it from the Descemet’s membrane and the Dua layer and 
replacing it with donor tissue [39, 43, 45, 46]. In the United States, according 
to the Eye Bank Association of America, DALK is the main indication of lamel-
lar transplantation, accounting for 43.4% of cases, and in countries such as the 
United Kingdom, Singapore, and Australia, this technique has taken up the last 
10 years [43].
There have been several techniques that have been developed, such as manual 
dissection/delamination of the corneal stroma or separation of the DM from the 
stroma using intrastromal injection of fluid, viscoelastic, hydro-delamination, 
or a big-bubble [40, 43]. Hydro-dissection is better than the others because it 
allows an easier dissection of the deep stroma and is more controlled than the 
rest [41], while Romano et al. [43] concluded that there was no significant differ-
ence between manual dissection and the big-bubble technique. In the same way, 
it has been decided that the best technique is with which each surgeon has more 
 experience [41].
Few of the advantages of this technique over penetrating keratoplasty (PKP) 
are the preservation of the host’s endothelium; a low rate of graft rejection; 
minimal loss of endothelial cells; lower postsurgical risk; a short term of steroid 
use during the postoperative period, reducing complications such as cataract, 
glaucoma, and late wound healing; and lower risk of intraocular infections; adding 
to this, Romano et al. [45] refer that it produces a stronger cornea, being less prone 
to spontaneous or posttraumatic wounds, as well as a longer graft survival than 
PKP [39, 43, 44, 47].
However, a fairly long learning curve is required, since the technique can 
be complicated for some surgeons, and the surgery time is longer than PKP; it 
also has unpredictable visual results compared to PKP since it takes between 6 
and 12 months to reach an acceptable visual acuity and generate high degrees of 
spherical and astigmatic refractive errors, and this depends on the thickness of the 
stromal bed or the presence of folds in the Descemet’s membrane; there may also be 
graft tears that require conversion to PKP [42–46].
The stromal bed is one of the factors that determine a good visual acuity after 
performing a DALK; several studies suggest that for better visual results, you should 
have a stromal bed less than 20 mm and not more than 65 mm, and these results are 
comparable to PKP [39, 45–47].
Moreover to the stromal bed and the folds in the Descemet’s membrane, 
other factors that can influence the variation of visual acuity and refractive 
errors have been determined, such as vitreous length, suture tension, the time 
at which sutures are removed, previous keratometric values, donor graft size, 
and donor-recipient disparity, which can modify the radius of corneal curvature 
[39–45, 48].
Corneal sutures are one of the most common morbidities in terms of poor visual 
acuity due to myopia and residual astigmatism that remain secondary to their 
withdrawal; in some studies it is said that residual myopia may become greater than 
in PK [40]. Therefore, it is recommended that suture removal be initiated in the 
1st month of operation and maximum between 18 and 24 months postoperatively 
[42–44]. This will depend on postoperative topographic astigmatism, which gener-
ally varies from >4 D to 6 D, as well as the loosening of sutures or their degradation 
or vascularization, taking into account that in PKP, the sutures remain longer than 
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in DALK [44, 45]; in any case, each patient should be assessed as graft dehiscence 
may occur that requires an early adjustment if they are not removed at the appropri-
ate time [40, 42, 43].
Refractive errors are the first causes of patient dissatisfaction. The most com-
mon refractive error is myopia due to lengthening of the posterior segment of 
the eye [40, 44] and can vary from −3.00 to −13.00 D [46]. Javadi et al. [42] 
determined that the spherical refraction remained stable after 6 months of suture 
extraction and refer that the refractive instability of DALK may be secondary to the 
avascular vertical wound between the donor and the recipient causing changes in 
the wound architecture during healing and in some cases due to the recurrence of 
keratoconus.
As for the spherical equivalent, Javadi et al. [42] indicate that the changes in 
it continued until 6 months after suture removal and remained stable afterward, 
in an average of 5 years, without changes in refractive astigmatism, and in some 
cases they recommend refractive surgery 6 months after the spherical equivalent is 
stabilized in patients who require it. Henein C et al. [48] conclude that the spherical 
equivalent did not vary between PK and DALK.
A preoperative UCVA of 20/100 and a preoperative BCVA of 20/40 are recom-
mended for DALK since this could result in a postoperative UCVA of 20/50 and a 
BCVA of 20/25 to 20/20 preoperative in a period of 36 months [43]. Javadi et al. 
[42] said that the patients evaluated obtained a postoperative visual acuity from 
20/30 to 20/40 at the end of the 60-month follow-up. And according to Huang et al. 
[44], there is no difference in refractive errors between DALK and PK and that a 
graft diameter size of 8.75–10.0 mm can achieve BCVA between 20/40 and 20/25 
and less apparent astigmatism than grafts of 8 mm and less spherical aberrations 
[39]. According to Romano et al. [43], the DALK is comparable with PK in terms of 
BCVA and refractive results as is Henein et al. [48].
According to a systematic review by Henein et al. [48], it was shown that 
BCVA and UCVA at 12 months of follow-up favored PK more than DALK, while 
better postoperative refractive astigmatism, lower episodes of graft rejection, and 
greater graft survival supported DALK more than PKP. However, the spherical 
equivalent and the density of endothelial cells did not vary between these two 
transplant techniques. They also report that the potential factors for postoperative 
keratometric and refractive astigmatism are the disparity of the donor graft, the 
bed of the host, and the degree of preoperative ametropia as some authors con-
clude [42–44, 46, 48].
It has been determined that factors such as central and peripheral corneal thick-
ness, recipient trepanation size, surgical technique, duration of steroid administra-
tion and elevated intraocular pressure do not contribute to postoperative refractive 
outcomes [40, 42, 45].
In a comparative study about visual results between DALK and PKP, it was 
determined that there were no significant differences in the best-corrected visual 
acuity between DALK and PKP at 12 and 24 months; however, patients who under-
went DALK were more recorded nearsighted without changes in the cylinder, with 
greater spherical equivalent than PKP [43, 47].
Some complications that can result from DALK are perforations of the recipient 
bed, double anterior chamber, corneal opacities, stromal rejection, high astigma-
tism, vascularization and/or loosening of the sutures, and elevation of intraocular 
pressure, which are usually controlled, have a very low incidence, and tend to be less 
frequent than the PKP [45–47].
In conclusion, according to several studies, DALK has many advantages over 
PKP for the treatment of mild or moderate keratoconus, with visual results that 
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tend to be unpredictable but similar to PKP, with a lower incidence of graft rejec-
tions and postoperative complications.
3. Conclusions
Up to date, there are several treatments that improve visual acuity in patients 
with keratoconus. The best method should be selected according to the characteris-
tics of each patient.
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